Trastuzumab Deruxtecan in HER2-Low Breast Cancer

被引：0
|
作者：
Carroll, Hailey K. [1 ]
Higgins, Michaela J. [2 ]
O'Reilly, Seamus [1 ]
机构：
[1] Cork Univ Hosp, Cork, Ireland
[2] St Vincents Univ Hosp, Dublin, Ireland
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 387卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1144 / 1144
页数：1
相关论文
共 50 条
  • [21] Response of Brain and Meningeal Metastases to Trastuzumab-Deruxtecan in a Patient with HER2-Low Breast Cancer: A Case Report
    Wolf, Benita
    Dunet, Vincent
    Dubruc, Estelle
    Dolcan, Ana
    Lalonde, Marie Nicod
    Schiappacasse, Luis
    Zaman, Khalil
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 1425 - 1435
  • [22] EXPOSURE-RESPONSE OF TRASTUZUMAB DERUXTECAN (T-DXD) IN SUBJECTS WITH HER2-LOW METASTATIC BREAST CANCER
    Lu, Z.
    Li, H.
    Wada, R.
    Li, L.
    Kamiyama, E.
    Vaddady, P.
    Abutarif, M.
    Garimella, T.
    Khatri, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S87 - S87
  • [23] Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2-Positive or HER2-Low Metastatic/Unresectable Breast Cancer
    Shimomura, Akihiko
    Takano, Toshimi
    Takahashi, Shunji
    Sagara, Yasuaki
    Watanabe, Junichiro
    Tokunaga, Eriko
    Shinkai, Tetsu
    Kamio, Takahiro
    Kikumori, Kunika
    Kamiyama, Emi
    Fujisaki, Yoshihiko
    Saotome, Dan
    Yamashita, Toshinari
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (01) : 160 - 169
  • [24] DIFFERENTIAL SURVIVAL IMPACT OF TRASTUZUMAB DERUXTECAN IN HER2-POSITIVE VERSUS HER2-LOW BREAST CANCER PATIENTS WITH BRAIN METASTASES
    Ranjan, Tulika
    Podder, Vivek
    Bardhan, Mainak
    Mccracken, Andrea
    Hurmiz, Charlie
    Mahtani, Reshma L.
    Ahluwalia, Manmeet Singh
    NEURO-ONCOLOGY, 2024, 26
  • [25] Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer
    Wolff, Antonio C.
    Mcshane, Lisa M.
    Allison, Kimberly H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08): : 829 - 831
  • [26] Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases
    Khatri, Vaseem M.
    Mestres-Villanueva, Mariella A.
    Yarlagadda, Sreenija
    Doniparthi, Ajay
    Smith, David B.
    Nakashima, Justyn Y.
    Bryant, John M.
    Zhao, Dekuang
    Upadhyay, Rituraj
    Mills, Matthew N.
    Oliver, Daniel E.
    Yu, Hsiang-Hsuan Michael
    Palmer, Joshua D.
    Williams, Nicole O.
    Mahtani, Reshma L.
    Ahluwalia, Manmeet S.
    Soliman, Hatem H.
    Han, Hyo S.
    Soyano, Aixa E.
    Kim, Youngchul
    Kotecha, Rupesh
    Beyer, Sasha J.
    Ahmed, Kamran A.
    NPJ BREAST CANCER, 2024, 10 (01)
  • [27] The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecan
    Schreiber, Anna R.
    O'Bryant, Cindy L.
    Kabos, Peter
    Diamond, Jennifer R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (10) : 1061 - 1069
  • [28] Trastuzumab-deruxtecan in HER2-low metastatic/unresectable breast cancer: Real life data in two Parisian centers
    Bieth, Claire
    Benderra, Marc Antoine
    Tichoue, Herve Foka
    Houari, Samy
    Hassani, Lamia
    Ghebriou, Djamel
    Seknazi, Lauren
    Barthere, Xavier
    Prebet, Coralie
    De Forceville, Louise
    Lotz, Jean-Pierre
    Gligorov, Joseph
    Jamelot, Mathieu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial
    Batista, M. Vaz
    Perez-Garcia, J. M.
    Cortez, P.
    Garrigos, L.
    Fernandez-Abad, M.
    Gion, M.
    Martinez-Bueno, A.
    Saavedra, C.
    Teruel, I.
    Fernandez-Ortega, A.
    Servitja, S.
    Ruiz-Borrego, M.
    de la Haba-Rodriguez, J.
    Martrat, G.
    Perez-Escuredo, J.
    Alcala-Lopez, D.
    Sampayo-Cordero, M.
    Braga, S.
    Cortes, J.
    Llombart-Cussac, A.
    ESMO OPEN, 2024, 9 (09)
  • [30] Trastuzumab deruxtecan for HER2+advanced breast cancer
    Lee, Jiyun
    Park, Yeon Hee
    FUTURE ONCOLOGY, 2021, 18 (01) : 7 - 19
12345